Identification of macrolide-resistant clones of Streptococcus pyogenes in Portugal

C Silva-Costa1, M Ramirez, J Melo-Cristino

  • 1Laboratório de Microbiologia, Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Lisboa, Lisbon, Portugal.

Insights

Macrolide resistance in Portugal remains stable, but dominant phenotypes are shifting. Genetic analysis revealed eight major clones, each linked to specific resistance types, with some clones circulating across Europe.

Area of Science:

  • Microbiology
  • Genetics
  • Epidemiology

Background:

  • Macrolide resistance in Portugal shows a stable overall level (27%) but a significant shift in dominant phenotypes.
  • A decrease in the MLS(B) phenotype and a corresponding increase in the M phenotype have been observed.

Purpose of the Study:

  • To investigate the genetic basis and clonal distribution underlying the changing macrolide resistance phenotypes in Portugal.
  • To characterize macrolide-resistant isolates using molecular typing techniques.

Main Methods:

  • Characterization of 325 macrolide-resistant isolates using pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST).
  • Utilized Cfr9I digestion for M phenotype isolates refractory to SmaI digestion to enable comparative analysis.
  • Concordant PFGE and MLST results identified major bacterial clones and their associated resistance phenotypes.

Main Results:

  • Eight major clones were identified, accounting for 92% of isolates, each exclusively associated with either MLS(B) or M macrolide resistance phenotype.
  • MLS(B) isolates were dominated by clones ST46 (T12/emm22) and ST52 (T28/emm28).
  • M isolates were primarily represented by clones ST39 (T4/emm4) and ST28 (T1/emm1). A previously described bacitracin-resistant clone (ST52) was identified, along with a novel variant.

Conclusions:

  • The observed shift in macrolide resistance phenotypes is driven by the emergence and dissemination of specific bacterial clones.
  • Four major clones identified in Portugal have also been reported in other European countries, indicating potential Europe-wide dissemination of macrolide-resistant lineages.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...